Industry: Pharmaceuticals, Biotechnology
Ranking:
Russell 3000
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its partners, the company is developing small molecule drugs. One of these drugs, BAY 43-9006, is in co-development with Bayer Pharmaceuticals Corporation. ( www.onyx-pharm.com )
Onyx Pharmaceuticals , Inc.
3031 Research Drive
Richmond, California 94806
USA
Tel: (510) 222-9700
Fax: (510) 222-9758